Navigation Links
Neural implant recovers ability to make decisions
Date:9/13/2012

Researchers have taken a key step towards recovering specific brain functions in sufferers of brain disease and injuries by successfully restoring the decision-making processes in monkeys.

By placing a neural device onto the front part of the monkeys' brains, the researchers, from Wake Forest Baptist Medical Centre, University of Kentucky and University of Southern California, were able to recover, and even improve, the monkeys' ability to make decisions when their normal cognitive functioning was disrupted.

The study, which has been published today, 14 September, in IOP Publishing's Journal of Neural Engineering, involved the use of a neural prosthesis, which consisted of an array of electrodes measuring the signals from neurons in the brain to calculate how the monkeys' ability to perform a memory task could be restored.

In the delayed match-to-sample task an image was flashed onto a screen and, after a delay, the monkeys were prompted to select the same image on the screen from a sampling which included 1-7 other images. Five monkeys (all rhesus, Macaca mulatta) were involved in the experiment and were trained for two years to perform to a 70-75 per cent proficiency in the task.

The movement of the monkeys' arms were tracked with a camera and translated to movements of the cursor on the screen; they were awarded with a drop of juice when they correctly matched an image.

The prosthesis was placed into two cortical layers L2/3 and L5 of the brain and recorded brain activity within structures known as minicolumns in the prefrontal cortex area.

Once it was confirmed that minicolumn communication between layers L2/3 and L5 was involved in decision making, it was supressed by administering the dopamine-modifying drug, cocaine, to the monkeys. The task was performed again but this time the researchers deployed a 'multi-input multi-output nonlinear' (MIMO) model to stimulate the neurons that were used in the task.

"The MIMO model is a specific type of calculation which looks for the complex mathematical relationship between an input (L2/3) and an output (L5). In the case of neural activity, the output is typically the pattern of firing of individual neurons during the task.

"Inputs to that pattern may be blood flow, temperature, the electrical activity of other neurons, and even the prior electrical activity of the same cell," said lead author of the study Professor Robert Hampson.

By recording the inputs from layer L2/3 neurons, the MIMO model could predict the output of layer L5 neurons and thus, through the electrodes, electrically stimulate the same necessary L5 neurons. The results showed that the MIMO model was exceedingly effective in recovering performance of the task and was even able to improve performance under normal conditions.

"The reason the MIMO model was effective in improving performance in the task was because we specifically 'tuned' the model to analyze the firing of neurons that occurred when the animals correctly performed the behavioral task; the brain doesn't always produce the full 'correct' pattern on every trial," said senior author Professor Sam Deadwyler

On the utilization of this method in the treatment of human brain conditions, Professor Deadwyler continued: "In the case of brain injury or disease where larger areas are affected, the system would record the inputs to that area from other areas and, when they occur, program the delivery of the appropriate output patterns to brain regions that normally receive signals from the injured area, thereby restoring lost brain function."

All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Wake Forest University, in accordance with U.S. Department of Agriculture, International Association for the Assessment and Accreditation of Laboratory Animal Care, and National Institutes of Health guidelines.


'/>"/>
Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Source:Eurekalert

Related biology technology :

1. Neuralstem ALS Stem Cell Trial Featured on Fox Atlanta
2. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
3. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
4. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
5. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. Triangles guide the way for live neural circuits in a dish
8. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
9. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions
10. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
11. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Bangkok, Thailand (PRWEB) , ... May 25, 2016 ... ... the participation of a Thai delegation at BIO 2016 in San Francisco. Located ... private sector will be available to answer questions and discuss the Thai biotechnology ...
(Date:5/25/2016)... ... May 25, 2016 , ... WEDI, the nation’s leading authority on the use ... W. Stellar has been named by the WEDI Board of Directors as WEDI’s president ... executive leader with more than 35 years of experience in healthcare, association management and ...
(Date:5/24/2016)... La Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... and financial planning for corporate executives and entrepreneurs, held The Future of San Diego ... leaders in the San Diego life science community attended the event with speakers Dr. ...
(Date:5/23/2016)... 23, 2016 Oxitec CEO Hadyn ... at 10:15 a.m. ET before the United States House Committee ... mosquitos can play in controlling the spread of the ... virus.      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) ... a self-limiting gene. Trials in Brazil , ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):